New research indicates that patients who stop using new GLP-1 drugs like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who end conventional diet and exercise regimens.
Findings released in a prominent health publication points out that while overweight individuals can lose substantial amounts of their body weight while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"People buying such drugs need to be informed of the danger of rapid rebound weight gain when the medication ends," cautioned lead investigator Dr. Susan Jebb.
This pace of regain means a return to pre-treatment weight within about 18 months.
Comparing Treatments
The analysis, which examined 37 of trials involving over 9,000 of participants, contrasted the outcomes of the injectable medications with conventional dieting.
The team note that people who lose weight through lifestyle changes alone usually have a more gradual creep back—perhaps 0.1 kg a month—after stopping.
The Reason for the Quick Regain
Experts believe the mechanism of the jabs explains the heightened rebound.
The injections copy a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of GLP-1 concentrations far above than normal might result in the body to generate a reduced amount of its endogenous hormone, and could reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this hormone supplement means hunger is no longer kept in check, making binge eating much more probable."
An Ongoing Condition?
The NHS recommend the jabs for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.
Professionals argue that, due to the likelihood of relapse, the treatment might need to be long-term.
This opinion is supported by drug manufacturers, who note that the findings "highlight the chronic nature of excess weight," akin to managing conditions like hypertension.
User Testimonies
People who have come off the jabs describe a sudden return of cravings.
"It felt as if a switch flipping and I was suddenly extremely hungry," recalled one woman.
This challenge is worsened if individuals have not developed sustainable lifestyle or habit modifications during therapy.
Significant Adoption
Recent estimates indicate that a significant number of adults in the UK have used these injections in the last 12 months, with desire being substantial.
- Adoption is greater among females than men.
- The 40s and 50s age group shows the highest usage rates.
- Many access the medications through private healthcare rather than the NHS.
In conclusion, experts caution that while GLP-1 drugs are effective tools for weight loss, they are not a magic fix and lasting health benefits hinges on combined lifestyle changes.